Drug potentiation against pre-erythrocytic stages of Plasmodium falciparum.
D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D010963:Plasmodium falciparum / Q000187:drug effects*; D013411:Sulfadiazine / Q000627:therapeutic use*; D013449:Sulfonamides / Q000008:administration & dosage; D013997:Time Factors; D014227:Triazines / Q000008:administration & dosage / Q000627:therapeutic use*
D005493:Folic Acid Antagonists; D013449:Sulfonamides; D014227:Triazines; D013411:Sulfadiazine